Safety and efficacy of topical formulations containing 0·5, 1 and 2% glycopyrronium bromide in patients with primary axillary hyperhidrosis: a randomized, double‐blind, placebo‐controlled study.

Autor: Masur, C., Soeberdt, M., Kilic, A., Knie, U., Abels, C.
Předmět:
Zdroj: British Journal of Dermatology; Jan2020, Vol. 182 Issue 1, p229-231, 3p
Abstrakt: Safety and efficacy of topical formulations containing 0-5, 1 and 2% glycopyrronium bromide in patients with primary axillary hyperhidrosis: a randomized, double-blind, placebo-controlled study Sweat reduction of more than 50% was achieved in 87-5% of patients treated with the 0-5% GPB cream ( I P i < 0-25 vs. pooled placebo) and in 100% of patients treated with the 1% or 2% GPB cream ( I P i < 0-06 vs. pooled placebo). A reduction in HDSS to a value of 1 was achieved in 100% of patients with the 2% GPB cream, in 75% with the 1% GPB cream and 37-5% with the 0-5% GPB cream. [Extracted from the article]
Databáze: Complementary Index
Externí odkaz: